Fresenius Medical Care | FME - Operating Profit


Fresenius Medical Care reported EUR384M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Akzo Nobel EUR -73M 324M Sep/2026
Alcon AG USD 44M 253M Jun/2026
AstraZeneca USD 4.66B 1.5B Sep/2026
Bayer EUR 129M 698M Sep/2026
Beiersdorf EUR 760M 256M Jun/2026
DaVita Healthcare Partners USD 570.82M 97.27M Jun/2026
Demant DKK 2.12B 35M Jun/2026
E.ON EUR 1.14B 2.97B Jun/2026
Essilor EUR 2.3B 919M Jun/2026
Fresenius EUR 639M 80M Sep/2026
Fresenius Medical Care EUR 384M 153.27M Sep/2026
Genmab DKK 407M 182M Jun/2026
Getinge SEK 1.35B 268M Jun/2026
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 2.86B 251M Sep/2026
GN Store Nord DKK 310M 252M Sep/2026
GRIFOLS EUR 394M 65M Sep/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Lonza CHF 673M 243M Jun/2025
Merck EUR 1.1B 51M Jun/2026
Novartis USD 5.14B 392M Sep/2026
Philips EUR 165M 445M Sep/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
RWE EUR 1.38B 1.52B Jun/2026
Sanofi EUR 4.72B 2.34B Sep/2026
SAP EUR 926M 1.72B Sep/2026
Smith & Nephew USD 505M 65M Jun/2026